BiotechTube
Home/Zenith Epigenetics/Donald McCaffrey
DM

Donald McCaffrey

President & Chief Executive Officer

Zenith Epigenetics

Therapeutic Areas

Oncology

Zenith Epigenetics Pipeline

DrugIndicationPhase
ZEN-3694Prostate Cancer (mCRPC)Phase 2
ZEN-3694 + CDK4/6iNUT CarcinomaProof-of-Concept